SYNAPTYS neuroscience

SYNAPTYS neuroscience is a biotechnology company developing a new therapeutic approach to modify the progression of Alzheimer's disease. Their mission is to act on the progression of this neurodegenerative disease to offer hope to millions of affected individuals and their families. They are developing SYS-0108, an innovative drug combination with multiple modes of action, currently in the preclinical phase, to transform the evolution of Alzheimer's disease and improve the quality of life for patients and their families.